Literature DB >> 30938876

Macrophage heterogeneity and plasticity in tuberculosis.

Arshad Khan1, Vipul Kumar Singh1, Robert L Hunter2, Chinnaswamy Jagannath1.   

Abstract

Macrophages are the primary host cells for Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), during its intracellular survival in humans. The pathogen has a remarkable capacity to survive within the hostile environment of macrophages. However, primary infection does not result in active TB disease in most individuals. The majority of individuals remain latently infected, wherein the bacteria are held in check by the host immune response. Nevertheless, such individuals can develop active TB later upon the decline in their immune status. In contrast, in a small fraction of infected individuals, the host immune response fails to control the growth of M. tuberculosis bacilli, and granulomatous TB develops progressively. Elucidating the molecular and phenotypic events that govern the outcome of the infection within macrophages is fundamental to understanding the key features of these cells that could be equally critical in infection control. The molecular details of the M. tuberculosis-macrophage interaction continue to be discerned, and emerging evidence suggests that macrophage population that participate in infection is heterogeneous. While the local environment and developmental origin could influence the phenotypic heterogeneity and functional plasticity of macrophages, M. tuberculosis has also been demonstrated to modulate the polarization of macrophages. In this review, we draw on work investigating specialized macrophage populations and their interactions with M. tuberculosis with respect to pathogenesis and specific immune responses. Understanding the mechanisms that control the repertoire of macrophage phenotypes and behaviors during infection may provide prospects for novel TB control strategies through modulation of immunobiological functions of macrophages. ©2019 Society for Leukocyte Biology.

Entities:  

Keywords:  M1 M2 macrophage phenotype; Mycobacterium tuberculosis, macrophages; alveolar macrophages; granuloma; polarization; tuberculosis

Year:  2019        PMID: 30938876     DOI: 10.1002/JLB.MR0318-095RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  25 in total

1.  Mycobacterial Trehalose 6,6'-Dimycolate-Induced M1-Type Inflammation.

Authors:  Thao K T Nguyen; John d'Aigle; Luis Chinea; Zainab Niaz; Robert L Hunter; Shen-An Hwang; Jeffrey K Actor
Journal:  Am J Pathol       Date:  2019-11-14       Impact factor: 4.307

2.  Macrophage innate training induced by IL-4 and IL-13 activation enhances OXPHOS driven anti-mycobacterial responses.

Authors:  Morgane Mitermite; Dylan Gerard Ryan; Mimmi L E Lundahl; Sarah Case; Niamh C Williams; Ming Yang; Roisin I Lynch; Eimear Lagan; Filipa M Lebre; Aoife L Gorman; Bojan Stojkovic; Adrian P Bracken; Christian Frezza; Frederick J Sheedy; Eoin M Scanlan; Luke A J O'Neill; Stephen V Gordon; Ed C Lavelle
Journal:  Elife       Date:  2022-09-29       Impact factor: 8.713

3.  [TRAF6 promotes Bacillus Calmette-Guérin-induced macrophage apoptosis through the intrinsic apoptosis pathway].

Authors:  Q Ma; L Liu; J Yu; Z Gong; X Wang; X Wu; G Deng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-09-20

Review 4.  Cellular Immunity of Patients with Tuberculosis Combined with Diabetes.

Authors:  Peng Cheng; Liang Wang; Wenping Gong
Journal:  J Immunol Res       Date:  2022-06-01       Impact factor: 4.493

5.  [Construction of macrophage RAW 264.7 cells with gsdmd gene knockout by CRISPR/Cas9 system].

Authors:  Liting Zhou; Ying Ye; Haibo Yuan; Chaoyi Wu; Shuyan Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-01-30

6.  Clinical Significance of M1/M2 Macrophages and Related Cytokines in Patients with Spinal Tuberculosis.

Authors:  Liang Wang; Xiaoqian Shang; Xinwei Qi; Derong Ba; Jie Lv; Xuan Zhou; Hao Wang; Nazierhan Shaxika; Jing Wang; Xiumin Ma
Journal:  Dis Markers       Date:  2020-05-20       Impact factor: 3.434

7.  Nitric Oxide-Dependent Electron Transport Chain Inhibition by the Cytochrome bc1 Inhibitor and Pretomanid Combination Kills Mycobacterium tuberculosis.

Authors:  Sheng Zeng; Jingran Zhang; Mingwei Sun; Xiaofei Zhang; Gregory M Cook; Tianyu Zhang
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

8.  FTY720 reactivates cryptococcal granulomas in mice through S1P receptor 3 on macrophages.

Authors:  Arielle M Bryan; Jeehyun Karen You; Travis McQuiston; Cristina Lazzarini; Zhijuan Qiu; Brian Sheridan; Barbara Nuesslein-Hildesheim; Maurizio Del Poeta
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

9.  Novel Role for Macrophage Galactose-Type Lectin-1 to Regulate Innate Immunity against Mycobacterium tuberculosis.

Authors:  Kubra F Naqvi; Matthew B Huante; Tais B Saito; Mark A Endsley; Benjamin B Gelman; Janice J Endsley
Journal:  J Immunol       Date:  2021-06-28       Impact factor: 5.426

10.  GM-CSF Dependent Differential Control of Mycobacterium tuberculosis Infection in Human and Mouse Macrophages: Is Macrophage Source of GM-CSF Critical to Tuberculosis Immunity?

Authors:  Abhishek Mishra; Vipul Kumar Singh; Jeffrey K Actor; Robert L Hunter; Chinnaswamy Jagannath; Selvakumar Subbian; Arshad Khan
Journal:  Front Immunol       Date:  2020-07-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.